Sadara’s First Plant up and Running

Sadara, claimed to be the world’s largest chemical complex ever built in a single phase, has started up its first production unit, an LLDPE plant using Dow Chemical’s technology. The complex is a joint venture of the Saudi Arabian Oil Company (Saudi Aramco) and Dow.

The 750,000 t/y unit, one of 26 production facilities to be built at the $20 billion complex in Jubail Industrial City II, is the first PE plant in the Middle East to use Dow’s Solution process. Its output will supply producers of specialties such as food grade plastics, industrial and consumer packaging and health and hygiene films.

Sadara’s site will also be the first in the Middle East to use refinery liquids such as naphtha as feedstock. Production units for LDPE and polyurethane precursors MDI, TDI and polyether polyols will be positioned downstream of the cracker with capacity for 1.5 million t/y of ethylene and 400,000 t/y of propylene.

The complex’s adjacent PlasChem Park, backed by Sadara and Saudi Arabia’s Royal Commission for Jubail and Yanbu and managed by Munich-based German chemical park management firm Chemie-Cluster Bayern, is wooing small- and medium-sized plastics converters and other users of standard thermoplastics to invest in the park.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.